A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo. - Filioglou, Dimitrios; Santa-Cruz, Nina; Leite, Geovana S. F.; Davini, Dan W.; Cracchiolo, Megan J.; Baker, Forrest L.; Husnain, Muhammad; Simpson, Richard J.; Voudouris, Vasilios; Katsanis, Emmanuel (Cancers, 2025)